Skip to content

Septerna, Inc. SEPN Restricted Cash

Restricted Cash at other companies

Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.23M+4,203%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$968K+7.4%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$105K0.0%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$4.17M-36.6%
ALN
Alnylam PharmaceuticalsALNY
$1.64M-36.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$1.73M+308%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s restricted cash?
Septerna, Inc. (SEPN) reported restricted cash of $905K in Q1 2026.
How has Septerna, Inc.'s restricted cash changed year-over-year?
Septerna, Inc.'s restricted cash decreased by 0.0% year-over-year, from $905K to $905K.
What is the long-term trend for Septerna, Inc.'s restricted cash?
Over 2 years (2023 to 2025), Septerna, Inc.'s restricted cash has grown at a 0.0% compound annual growth rate (CAGR), from $905K to $905K.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.